A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

NewLimit Raises $435M to advance longevity medicine trials, expand ageing research programmes and accelerate clinical growth.

AACR Trailblazer Grant recipients are tackling fundamental questions in cancer biology—from metastasis and immune evasion to ...

A fresh debate around AI, healthcare and the future of human ageing has exploded online after a viral X post by Ricardo, a private content partner covering finance and technology founders, resurfaced ...

Cancer immunotherapy has entered a transformative era, providing durable benefits to many patients. However, a substantial subset of malignancies remains ...

Medical University of South Carolina (MUSC) researchers have developed an engineered stem cell treatment capable of reversing ...

Doha – Prof. Hilal A. Lashuel, professor of neuroscience in neurology at Weill Cornell Medicine-Qatar (WCM-Q) – a Qatar Foundation partner university - has been awarded a $9 million three-year ...

R3 Bio wants to grow human bodies without brains, which could replace lab animals in drug research and one day supply organs ...

NewLimit has come up with a new anti-aging breakthrough by developing a drug that can reverse the aging in human cells.

Tribune News NetworkDoha Prof. Hilal A. Lashuel, professor of neuroscience in neurology at Weill Cornell Medicine-Qatar (WCM-Q), a Qatar Foundation partner university, has been awarded a $9 million ...